Swiss HIV Cohort Study
Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study
Bernasconi E, Telenti A, Rickenbach M, Weber R, Opravil M, Chave J, Boggian K, Hirschel B, Haensel A, Furrer H, Flepp M, Junghans C, Boubaker K, Swiss HIV Cohort Study. Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study. J Acquir Immune Defic Syndr 2002; 31:50-5.
Sep 1, 2002Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study
Sep 1, 2002J Acquir Immune Defic Syndr 2002; 31:50-5
Bernasconi Enos, Telenti Amalio, Rickenbach Martin, Weber Rainer, Opravil Milos, Chave Jean-Philippe, Boggian Katia, Hirschel Bernard, Haensel Alexander, Furrer Hans-Jakob, Flepp Markus, Junghans Cornelia, Boubaker Karim, Swiss HIV Cohort Study
A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection
Opravil M, Perrin L, Weber R, Howe C, Günthard H, Ledergerber B, Battegay M, Bernasconi E, Vernazza P, Fischer M, Bisset L, Yerly S, Chave J, Furrer H, Lazzarin A, Hirschel B, Swiss HIV Cohort Study. A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection. The Journal of infectious diseases 2002; 185:1251-60.
May 1, 2002A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection
May 1, 2002The Journal of infectious diseases 2002; 185:1251-60
Opravil Milos, Perrin Luc, Weber Rainer, Howe Colin, Günthard Huldrych, Ledergerber Bruno, Battegay Manuel, Bernasconi Enos, Vernazza Pietro, Fischer Marek, Bisset Leslie R, Yerly Sabine, Chave Jean-Philippe, Furrer Hansjakob, Lazzarin Adriano, Hirschel Bernard, Swiss HIV Cohort Study
Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study
Fellay J, Telenti A, Eap C, Vernazza P, Schinkel A, Ruiz L, Retelska D, Pantaleo G, Opravil M, Furrer H, Decosterd L, Chave J, Buclin T, Back D, Meaden E, Marzolini C, Swiss HIV Cohort Study. Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study. Lancet 2002; 359:30-6.
Jan 5, 2002Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study
Jan 5, 2002Lancet 2002; 359:30-6
Fellay Jacques, Telenti Amalio, Eap Chin B, Vernazza Pietro, Schinkel Alfred H, Ruiz Lidia, Retelska Dorota, Pantaleo Giuseppe, Opravil Milos, Furrer Hansjakob, Decosterd Laurent A, Chave Jean Philippe, Buclin Thierry, Back David J, Meaden Emma R, Marzolini Catia, Swiss HIV Cohort Study
HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load
Phillips A, Frakfurt HIV Clinic Cohort, Swiss HIV Cohort Study, Ledergerber B, Lundgren J, Vernazza P, Miller V, Francioli P, Kirk O, Weber R, Staszewski S, EuroSIDA Study Group. HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load. JAMA : the journal of the American Medical Association 2001; 286:2560-7.
Nov 28, 2001HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load
Nov 28, 2001JAMA : the journal of the American Medical Association 2001; 286:2560-7
Phillips A N, Frakfurt HIV Clinic Cohort, Swiss HIV Cohort Study, Ledergerber B, Lundgren J D, Vernazza Pietro, Miller V, Francioli P, Kirk O, Weber R, Staszewski S, EuroSIDA Study Group
Acute HIV infection: impact on the spread of HIV and transmission of drug resistance
Yerly S, Perrin L, Hirschel B, Rickenbach M, Bru J, Veuthey A, Battegay M, Telenti A, Flepp M, Vernazza P, Chave J, Rizzardi P, Vora S, Swiss HIV Cohort Study. Acute HIV infection: impact on the spread of HIV and transmission of drug resistance. AIDS (London, England) 2001; 15:2287-92.
Nov 23, 2001Acute HIV infection: impact on the spread of HIV and transmission of drug resistance
Nov 23, 2001AIDS (London, England) 2001; 15:2287-92
Yerly S, Perrin L, Hirschel B, Rickenbach M, Bru J P, Veuthey A L, Battegay M, Telenti A, Flepp M, Vernazza Pietro, Chave J P, Rizzardi P, Vora S, Swiss HIV Cohort Study
Importance of mental health assessment in HIV-infected outpatients
Zinkernagel C, Battegay M, Vernazza P, Werder V, Kiss A, Rauchfleisch U, Volkart A, Ledergerber B, Amiet R, Rickenbach M, Taffé P, Swiss HIV Cohort Study. Importance of mental health assessment in HIV-infected outpatients. Journal of acquired immune deficiency syndromes (1999) 2001; 28:240-9.
Nov 1, 2001Importance of mental health assessment in HIV-infected outpatients
Nov 1, 2001Journal of acquired immune deficiency syndromes (1999) 2001; 28:240-9
Zinkernagel C, Battegay M, Vernazza Pietro, Werder V, Kiss A, Rauchfleisch U, Volkart A C, Ledergerber B, Amiet R, Rickenbach M, Taffé P, Swiss HIV Cohort Study
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study
Fellay J, Telenti A, Flepp M, Greub G, Francioli P, Vernazza P, Hirschel B, Battegay M, Furrer H, Bernasconi E, Ledergerber B, Boubaker K, Swiss HIV Cohort Study. Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet 2001; 358:1322-7.
Oct 20, 2001Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study
Oct 20, 2001Lancet 2001; 358:1322-7
Fellay J, Telenti A, Flepp M, Greub G, Francioli P, Vernazza Pietro, Hirschel B, Battegay M, Furrer H, Bernasconi E, Ledergerber B, Boubaker K, Swiss HIV Cohort Study
A single-nucleotide polymorphism in the sterol-regulatory element-binding protein 1c gene is predictive of HIV-related hyperlipoproteinaemia
Miserez A, Muller P, Barella L, Schwietert M, Erb P, Vernazza P, Battegay M, Swiss HIV Cohort Study. A single-nucleotide polymorphism in the sterol-regulatory element-binding protein 1c gene is predictive of HIV-related hyperlipoproteinaemia. AIDS (London, England) 2001; 15:2045-9.
Oct 19, 2001A single-nucleotide polymorphism in the sterol-regulatory element-binding protein 1c gene is predictive of HIV-related hyperlipoproteinaemia
Oct 19, 2001AIDS (London, England) 2001; 15:2045-9
Miserez A R, Muller P Y, Barella L, Schwietert M, Erb P, Vernazza Pietro, Battegay M, Swiss HIV Cohort Study
Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapy
Rossi M, Furrer H, Rickenbach M, Weber R, Bernasconi E, Vernazza P, Bucher H, Egloff N, Schiffer V, Telenti A, Flepp M, Swiss HIV Cohort Study. Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapy. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2001; 131:471-7.
Aug 11, 2001Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapy
Aug 11, 2001Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2001; 131:471-7
Rossi M, Furrer H, Rickenbach M, Weber R, Bernasconi E, Vernazza Pietro, Bucher H, Egloff N, Schiffer V, Telenti A, Flepp M, Swiss HIV Cohort Study
Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infection
Bisset L, Opravil M, Grob P, Weber R, Dubs R, Vernazza P, Battegay M, Fischer M, Cone R, Swiss HIV Cohort Study. Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infection. Journal of acquired immune deficiency syndromes (1999) 2001; 27:266-71.
Jul 1, 2001Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infection
Jul 1, 2001Journal of acquired immune deficiency syndromes (1999) 2001; 27:266-71
Bisset L R, Opravil M, Grob P J, Weber R, Dubs R W, Vernazza Pietro, Battegay M, Fischer M, Cone R W, Swiss HIV Cohort Study
HIV transmission after suspension of highly active antiretroviral therapy
Bernasconi E, Vernazza P, Bernasconi A, Hirschel B, Swiss HIV Cohort Study. HIV transmission after suspension of highly active antiretroviral therapy. Journal of acquired immune deficiency syndromes (1999) 2001; 27:209.
Jun 1, 2001HIV transmission after suspension of highly active antiretroviral therapy
Jun 1, 2001Journal of acquired immune deficiency syndromes (1999) 2001; 27:209
Bernasconi E, Vernazza Pietro, Bernasconi A, Hirschel B, Swiss HIV Cohort Study
Longitudinal sero-reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS
Quinlivan E, Wang R, Stewart P, Kolmoltri C, Regamey N, Erb P, Vernazza P, Swiss HIV Cohort Study. Longitudinal sero-reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS. Journal of medical virology 2001; 64:157-66.
Jun 1, 2001Longitudinal sero-reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS
Jun 1, 2001Journal of medical virology 2001; 64:157-66
Quinlivan E B, Wang R X, Stewart P W, Kolmoltri C, Regamey N, Erb P, Vernazza Pietro, Swiss HIV Cohort Study
Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre study
Furrer H, Egger M, Flepp M, Rickenbach M, Boggian K, Schiffer V, Bucher H, Telenti A, Bernasconi E, Rossi M, Opravil M, Swiss HIV Cohort Study. Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre study. AIDS 2001; 15:501-7.
Mar 9, 2001Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre study
Mar 9, 2001AIDS 2001; 15:501-7
Furrer H, Egger M, Flepp M, Rickenbach M, Boggian Katia, Schiffer V, Bucher H, Telenti A, Bernasconi E, Rossi M, Opravil M, Swiss HIV Cohort Study
Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patients
Battegay M, Hirschel B, Bedoucha V, Morgenthaler S, Jaccard C, Malinverni R, Erb P, Sendi P, Flepp M, Bernasconi E, Vernazza P, Swiss HIV Cohort Study. Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patients. HIV medicine 2001; 2:35-42.
Jan 1, 2001Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patients
Jan 1, 2001HIV medicine 2001; 2:35-42
Battegay M, Hirschel B, Bedoucha V, Morgenthaler S, Jaccard C, Malinverni R, Erb P, Sendi P, Flepp M, Bernasconi E, Vernazza Pietro, Swiss HIV Cohort Study